AU5311901A - A gene differentially expressed in breast and bladder cancer and encoded polypeptides - Google Patents

A gene differentially expressed in breast and bladder cancer and encoded polypeptides

Info

Publication number
AU5311901A
AU5311901A AU5311901A AU5311901A AU5311901A AU 5311901 A AU5311901 A AU 5311901A AU 5311901 A AU5311901 A AU 5311901A AU 5311901 A AU5311901 A AU 5311901A AU 5311901 A AU5311901 A AU 5311901A
Authority
AU
Australia
Prior art keywords
differentially expressed
breast
bladder cancer
encoded polypeptides
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU5311901A
Other languages
English (en)
Inventor
Maurice Zauderer
Elizabeth E Evans
Melinda A Borrello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Publication of AU5311901A publication Critical patent/AU5311901A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU5311901A 2000-04-04 2001-04-04 A gene differentially expressed in breast and bladder cancer and encoded polypeptides Pending AU5311901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19446300P 2000-04-04 2000-04-04
PCT/US2001/010855 WO2001074859A2 (en) 2000-04-04 2001-04-04 A gene differentially expressed in breast and bladder cancer and encoded polypeptides

Publications (1)

Publication Number Publication Date
AU5311901A true AU5311901A (en) 2001-10-15

Family

ID=22717696

Family Applications (2)

Application Number Title Priority Date Filing Date
AU5311901A Pending AU5311901A (en) 2000-04-04 2001-04-04 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
AU2001253119A Ceased AU2001253119B2 (en) 2000-04-04 2001-04-04 A gene differentially expressed in breast and bladder cancer and encoded polypeptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001253119A Ceased AU2001253119B2 (en) 2000-04-04 2001-04-04 A gene differentially expressed in breast and bladder cancer and encoded polypeptides

Country Status (10)

Country Link
US (3) US7268207B2 (enExample)
EP (1) EP1272636B8 (enExample)
JP (1) JP2004502408A (enExample)
CN (2) CN101643732A (enExample)
AT (1) ATE404669T1 (enExample)
AU (2) AU5311901A (enExample)
CA (1) CA2413211A1 (enExample)
DE (1) DE60135315D1 (enExample)
NZ (1) NZ522282A (enExample)
WO (1) WO2001074859A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2413211A1 (en) 2000-04-04 2001-10-11 University Of Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
US7135278B1 (en) 2000-09-29 2006-11-14 University Of Rochester Method of screening for therapeutics for infectious diseases
EP1359937A4 (en) * 2001-02-14 2004-07-28 Genzyme Corp MODIFIED PEPTIDE LIGANDS
AU2002322280A1 (en) * 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2003274463B2 (en) * 2002-06-10 2009-10-29 University Of Rochester Gene differentially expressed in breast and bladder cancer and encoded polypeptides
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
WO2004087058A2 (en) * 2003-03-28 2004-10-14 Vaccinex, Inc. Targeted mhc class i alpha3 vaccine delivery systems
WO2005099361A2 (en) * 2003-07-10 2005-10-27 Vaccinex, Inc. MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
WO2005055936A2 (en) * 2003-12-04 2005-06-23 Vaccinex, Inc. Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
US20050266425A1 (en) * 2003-12-31 2005-12-01 Vaccinex, Inc. Methods for producing and identifying multispecific antibodies
US20050260659A1 (en) * 2004-04-23 2005-11-24 Exagen Diagnostics, Inc. Compositions and methods for breast cancer prognosis
AU2007261247A1 (en) * 2006-06-22 2007-12-27 Vaccinex, Inc. Anti-C35 antibodies for treating cancer
EP2112930B1 (en) * 2007-02-21 2017-01-11 Vaccinex, Inc. Modulation of nkt cell activity with antigen-loaded cdid molecules
US20090136465A1 (en) 2007-09-28 2009-05-28 Intrexon Corporation Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
NZ586544A (en) 2007-12-26 2012-07-27 Vaccinex Inc Anti-c35 antibody in combination with an ani-her2 antibody in cancer therapies and methods
KR101928684B1 (ko) 2009-01-08 2018-12-12 앨버트 아인슈타인 컬리지 오브 메디신, 인크. 세포벽 결합 세라미드 유사 당지질을 갖는 박테리아 백신 및 이의 용도
EP2413968B1 (en) * 2009-04-01 2017-05-17 The University Of British Columbia Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
US8946379B2 (en) 2009-09-24 2015-02-03 The Regents Of The University Of California Bladder cancer specific ligand peptides
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
JP7114477B2 (ja) * 2015-12-16 2022-08-08 グリットストーン バイオ インコーポレイテッド 新生抗原の特定、製造、および使用
KR102946326B1 (ko) * 2017-09-05 2026-03-31 시애틀 프로젝트 코포레이션 T-세포 요법을 위한 신생항원 동정
CN111465989B (zh) 2017-10-10 2024-06-25 磨石生物公司 使用热点进行的新抗原鉴别
AU2018373154B2 (en) 2017-11-22 2025-08-07 Seattle Project Corp. Reducing junction epitope presentation for neoantigens
CN112243463B (zh) 2018-04-09 2024-12-13 小利兰·斯坦福大学托管委员会 原位基因测序方法
KR102318018B1 (ko) 2019-07-05 2021-10-28 한국생산기술연구원 마이크로 제품 제작용 맨드렐 제작 방법, 마이크로 제품 제작용 몰드 제작 방법 및 마이크로 제품 제작용 몰드
KR20220100589A (ko) * 2019-10-18 2022-07-15 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 임상 및 산업 규모의 온전한 조직 시퀀싱
CN115407064B (zh) * 2021-05-26 2025-09-23 复旦大学附属肿瘤医院 肿瘤干细胞血管拟态标志物tem8在制备诊断试剂和试剂盒中的用途
US20240409582A1 (en) * 2022-08-23 2024-12-12 The University of North Texas Health Sciences Cente Design and characterization of inhibitory peptides (ipeps) derived from of mien 1 protein sequence

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0581600A (ja) * 1991-04-18 1993-04-02 Fujitsu Ltd 双曲線航法システムにおけるシステム監視処理方式
IL106610A0 (en) 1992-08-07 1993-12-08 Cytel Corp Hla binding peptides and their uses
SG49008A1 (en) 1993-03-05 1998-05-18 Cytel Corp Hla-a2.1 binding peptides and their uses
US5856131A (en) * 1997-02-24 1999-01-05 Incyte Pharmaceuticals, Inc. Human selenoprotein
US7026447B2 (en) * 1997-10-09 2006-04-11 Human Genome Sciences, Inc. 53 human secreted proteins
CA2316397A1 (en) 1997-12-24 1999-07-08 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU2342299A (en) * 1998-01-26 1999-08-09 Genquest Inc. Compositions and methods for detecting and treating breast cancer
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
CA2413211A1 (en) * 2000-04-04 2001-10-11 University Of Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
AU5532601A (en) * 2000-04-12 2001-10-30 Univ Rochester Targeted vaccine delivery systems
US20050196755A1 (en) * 2000-11-17 2005-09-08 Maurice Zauderer In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
CN1306272C (zh) * 2000-11-17 2007-03-21 罗切斯特大学 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的方法
AU2003274463B2 (en) * 2002-06-10 2009-10-29 University Of Rochester Gene differentially expressed in breast and bladder cancer and encoded polypeptides
WO2005099361A2 (en) * 2003-07-10 2005-10-27 Vaccinex, Inc. MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
WO2005055936A2 (en) * 2003-12-04 2005-06-23 Vaccinex, Inc. Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells

Also Published As

Publication number Publication date
EP1272636B1 (en) 2008-08-13
US20020155447A1 (en) 2002-10-24
EP1272636A2 (en) 2003-01-08
US20090312263A1 (en) 2009-12-17
EP1272636B8 (en) 2008-10-08
WO2001074859A3 (en) 2002-03-28
NZ522282A (en) 2005-03-24
JP2004502408A (ja) 2004-01-29
US20070081942A1 (en) 2007-04-12
ATE404669T1 (de) 2008-08-15
CA2413211A1 (en) 2001-10-11
US7268207B2 (en) 2007-09-11
CN101643732A (zh) 2010-02-10
DE60135315D1 (de) 2008-09-25
WO2001074859A2 (en) 2001-10-11
US7910551B2 (en) 2011-03-22
AU2001253119B2 (en) 2006-04-13
CN1610743A (zh) 2005-04-27

Similar Documents

Publication Publication Date Title
EP1272636B8 (en) A gene differentially expressed in breast and bladder cancer and encoded polypeptides
WO2002016413A8 (en) Cripto tumour polypeptide
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
WO2001062920A3 (en) Compositions and methods for diagnosis and therapy of malignant mesothelioma
PT1200590E (pt) Antigénio transmembranar lectina tipo c expresso em cancro da próstata humano e utilizações do mesmo
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
WO2001073032A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2004113571A3 (en) Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
HUP0203968A2 (hu) Készítmények és eljárások prosztatarák terápiájára és diagnózisára
WO2002089747A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
PT1228208E (pt) 36p6d5: antigénio tumoral secretado
WO2004070062A3 (en) Compositions and methods for diagnosing and treating cancers
WO2002078516A3 (en) Compositions and methods for the therapy and diagnosis of cancer
WO2000055180A3 (en) Human lung cancer associated gene sequences and polypeptides
WO1999051263A3 (en) Methods and modified cells for the treatment of cancer
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
WO2001090152A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2000061753A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO2001079557A3 (en) Gtp-binding protein useful in treatment and detection of cancer
WO2002066506A3 (en) Use of casb7439 (ash2) in the immunotherapy of breast cancer
WO2006037485A3 (en) Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy
DE60130541D1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten